Verastem Analyst Price Targets - Benzinga

Verastem Inc

VSTMNASDAQ

Trade with Public

Trade with Public

$7.22

N/A

At close: Aug 31, 5:00 PM EST

$7.21

-0.01-0.14%

After Hours: 6:57 PM EST

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Verastem Analyst Price Targets

Wall Street analyst price targets and consensus rating for Verastem (VSTM).

Price Target Range — 12 Quarters

Analyst Consensus — 10 Analysts

10Buy

Consensus RatingBuy# Analysts10Avg. Consensus PT$14Upside to Avg. PT+96.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 11, 2026	Mizuho	Graig Suvannavejh	PT Cut	Outperform	$14→$13
Aug 7, 2026	Guggenheim	Michael Schmidt	PT Cut	Buy	$14→$12
Jul 7, 2026	RBC Capital	Leonid Timashev	PT Cut	Outperform	$15→$14
Jul 2, 2026	BTIG	Jeet Mukherjee	Maintained	Buy	$18
Jun 24, 2026	HC Wainwright & Co.	Andres Y. Maldonado	Maintained	Buy	$18
Jun 24, 2026	BTIG	Jeet Mukherjee	Maintained	Buy	$18
Jun 23, 2026	Jefferies	Faisal Khurshid	PT Cut	Buy	$15→$8
May 14, 2026	Mizuho	Graig Suvannavejh	PT Cut	Outperform	$16→$14
May 8, 2026	BTIG	Jeet Mukherjee	PT Cut	Buy	$19→$18
Apr 23, 2026	BTIG	Jeet Mukherjee	Maintained	Buy	$19
Apr 20, 2026	BTIG	Jeet Mukherjee	Maintained	Buy	$19
Apr 10, 2026	BTIG	Jeet Mukherjee	Maintained	Buy	$19
Apr 10, 2026	HC Wainwright & Co.	Andres Y. Maldonado	Maintained	Buy	$18
Mar 30, 2026	Jefferies	Faisal Khurshid	Assumes	Buy	$19→$15
Mar 12, 2026	BTIG	Jeet Mukherjee	Assumes	Buy	$19
Feb 4, 2026	HC Wainwright & Co.	Andres Y. Maldonado	Assumes	Buy	$18
Oct 16, 2025	Cantor Fitzgerald	Eric Schmidt	Assumes	Overweight	—
Sep 9, 2025	BTIG	Justin Zelin	Maintained	Buy	$20
Aug 8, 2025	RBC Capital	Leonid Timashev	PT Raise	Outperform	$12→$13
Jun 25, 2025	RBC Capital	Leonid Timashev	PT Cut	Outperform	$16→$12

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Mizuho Maintains Outperform on Verastem, Lowers Price Target to $13

Mizuho analyst Graig Suvannavejh maintains Verastem (NASDAQ:VSTM) with a Outperform and lowers the price target from $14 to $13.

Benzinga Newsdesk

PRO
Guggenheim Maintains Buy on Verastem, Lowers Price Target to $12

Guggenheim analyst Michael Schmidt maintains Verastem (NASDAQ:VSTM) with a Buy and lowers the price target from $14 to $12.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Verastem, Lowers Price Target to $14

RBC Capital analyst Leonid Timashev maintains Verastem (NASDAQ:VSTM) with a Outperform and lowers the price target from $15 to $14.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Verastem, Maintains $18 Price Target

HC Wainwright & Co. analyst Andres Y. Maldonado reiterates Verastem (NASDAQ:VSTM) with a Buy and maintains $18 price target.

Benzinga Newsdesk

PRO
BTIG Reiterates Buy on Verastem, Maintains $18 Price Target

BTIG analyst Jeet Mukherjee reiterates Verastem (NASDAQ:VSTM) with a Buy and maintains $18 price target.

Benzinga Newsdesk

PRO
Mizuho Maintains Outperform on Verastem, Lowers Price Target to $14

Mizuho analyst Graig Suvannavejh maintains Verastem (NASDAQ:VSTM) with a Outperform and lowers the price target from $16 to $14.

Benzinga Newsdesk